These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 27324965

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma.
    Hosono A, Yamaguchi U, Makimoto A, Endo M, Watanabe A, Shimoda T, Kaya M, Matsumura T, Sonobe H, Kusumi T, Yamaguchi T, Hasegawa T.
    J Clin Pathol; 2007 Apr; 60(4):410-4. PubMed ID: 16822878
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors.
    Tanic M, Yanowski K, Gómez-López G, Rodriguez-Pinilla MS, Marquez-Rodas I, Osorio A, Pisano DG, Martinez-Delgado B, Benítez J.
    Int J Cancer; 2015 Feb 01; 136(3):593-602. PubMed ID: 24917463
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
    Ghanbari R, Rezasoltani S, Hashemi J, Mohamadkhani A, Tahmasebifar A, Arefian E, Mobarra N, Asadi J, Nazemalhosseini Mojarad E, Yazdani Y, Knuutila S, Malekzadeh R.
    Arch Iran Med; 2017 Feb 01; 20(2):92-95. PubMed ID: 28193082
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Expression of BKV and JCV encoded microRNA in human cerebrospinal fluid, plasma and urine.
    Pietilä T, Nummi M, Auvinen P, Mannonen L, Auvinen E.
    J Clin Virol; 2015 Apr 01; 65():1-5. PubMed ID: 25766978
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K.
    Int J Cancer; 2010 Mar 01; 126(5):1166-76. PubMed ID: 19676045
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H, Yin Z, Ning K, Wang L, Guo R, Ji Z.
    Hum Pathol; 2014 Jul 01; 45(7):1430-6. PubMed ID: 24784921
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O, Kara M, Yumrutas O, Bozgeyik E, Bozgeyik I, Celik OI.
    Tumour Biol; 2016 May 01; 37(5):6637-45. PubMed ID: 26643896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.